Investors can the law firm at no cost to learn more about recovering their losses
LOS ANGELES, June 19, 2023 (GLOBE NEWSWIRE) — advises NovoCure Limited (“NovoCure” or the “Company”) (NASDAQ: NVCR) investors that a lawsuit filed on behalf of investors that purchased NovoCure securities between January 5, 2023 to June 5, inclusive (the “Class Period”)
Investors are encouraged to contact an attorney by phone 844-767-8529 or : [email protected], to discuss their legal rights, or to join the case via . The Portnoy Law Firm can provide a free case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The complaint asserts that the defendants engaged in false and/or deceptive statements and/or omitted important information, claiming the following:
- The Company concealed the true nature of the LUNAR study data, which involved a relatively small percentage of participants who were receiving standard of care therapy.
- Consequently, the reliability of the data in demonstrating clinical efficacy was significantly compromised.
- The disclosure of this information had a reasonable likelihood of negatively affecting the Company’s regulatory prospects and overall operations.
- As a result, the Company’s public statements made during the relevant times were materially false and misleading.
The allegations suggest that the defendants misrepresented the LUNAR study data and its impact, leading to potential negative consequences for the Company’s regulatory prospects and operations.
Please visit us to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against causes caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
310-692-8883
www.portnoylaw.com
Attorney Advertising
